Neuroalojen ja kuntoutuksen vastuualue

Julkaisut 2017
Publications 2017

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aivo J et al. Risk of osteoporotic fractures in multiple sclerosis patients in southwest Finland.
2 Arola H et al. Aslak-kuntoutuksen vaikutus sairauspissaoloihin sekä työterveyshuollon käyttöön ja kustannuksiin.
3 Balcin H et al. Late-onset limb-girdle muscular dystrophy caused by GMPPB mutations.
4 Basnyat P et al. JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients.
5 Bauer J et al. Innate and adaptive immunity in human epilepsies.
6 Berger T et al. Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts.
7 Cukiert A, Lehtimäki K. Deep brain stimulation targeting in refractory epilepsy.
8 Fisher R et al. Instruction manual for the ILAE 2017 operational classification of seizure types.
9 Fisher R et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology.
10 Fisher R et al. Response to the numbering of seizure types.
11 Fitzgerald K et al. Sodium intake and multiple sclerosis activity and progression in BENEFIT.
12 Garber M et al. A B-Cell Gene Signature Correlates With the Extent of Gluten-Induced Intestinal Injury in Celiac Disease .
13 Granberg K et al. Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.
14 Hackman P et al. 219th ENMC International Workshop Titinopathies International database of titin mutations and phenotypes, Heemskerk, The Netherlands, 29 April-1 May 2016.
15 Hänninen T. The Sport Concussion Assessment Tool in the Management of Concussion in Professional Ice Hockey.
16 Hänninen T et al. Interpreting change on the SCAT3 in professional ice hockey players.
17 Ihalainen T et al. Reply to Saeid Safiri's Letter to the Editor: Risk factors for laryngeal penetration-aspiration in patients with acute traumatic cervical spinal cord injury.
18 Ihalainen T et al. Traumatic cervical spinal cord injury: a prospective clinical study of laryngeal penetration and aspiration.
19 Ilvesmäki T et al. Spinal cord injury induces widespread chronic changes in cerebral white matter.
20 Isokuortti H. Acute mild traumatic brain injury, pre-injury health and structural imaging findings.
21 Johari M et al. Association study reveals novel risk loci for sporadic inclusion body myositis.
22 Jokela M et al. Gluteus maximus hypertrophy: A diagnostic clue in four and a half LIM domain 1-mutated reducing body myopathy.
23 Järventausta K et al. Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression.
24 Kalliokoski S et al. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
25 Kiiski H et al. Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Is Not Associated with Neurological Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage.
26 Kiiski H et al. Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage.
27 Koivisto T, Luoto T. Kallo- ja aivovammat .
28 Koivisto T, Luoto T. Hyvin lievä ja lievä aivovamma .
29 Koivisto T, Luoto T. Aivoruhjevamma.
30 Koivisto T, Luoto T. Kallonsisäiset traumaattiset verenkeräymät.
31 Koskinen E et al. Selkäydinvammojen ilmaantuvuus on ennakoitua suurempi.
32 Lamusuo S et al. Unenaikaiset hengityshäiriöt aikuisilla epilepsiapotilailla.
33 Lehtimäki K et al. Successful management of super-refractory status epilepticus with thalamic deep brain stimulation.
34 Liimatainen S et al. Aivovammojen hyvä hoito perustuu yhtenäiseen diagnostiikkaan.
35 Luoto TM et al. A Systematic Review of the Usefulness of Glial Fibrillary Acidic Protein for Predicting Acute Intracranial Lesions following Head Trauma.
36 Metso S et al. Aivolisäkekasvainten diagnostiikka.
37 Mäki-Marttunen V et al. Greater Attention to Task-Relevant Threat Due to Orbitofrontal Lesion.
38 Mäkinen J et al. Aikuisten epilepsian lääkehoidon valinnat.
39 Mäkinen J et al. Comparative effectiveness of eight antiepileptic drugs in adults with focal refractory epilepsy: the influence of age, gender, and the sequence in which drugs were introduced onto the market.
40 Mäkinen J et al. Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.
41 Mäkinen J et al. The effect of newer antiepileptic drugs in combination therapy.
42 Palmio J, Laaksovirta H. ALS-potilaan monimuotoiset oireet.
43 Palmio J et al. Predominantly myalgic phenotype caused by the c.3466G>A p.A1156T mutation in SCN4A gene.
44 Pasanen P et al. Primary familial brain calcification linked to deletion of 5' noncoding region of SLC20A2.
45 Penttilä S et al. CHCHD10 mutations and motor neuron disease: the distribution in Finnish patients.
46 Peräkylä J et al. Causal Evidence from Humans for the Role of Mediodorsal Nucleus of the Thalamus in Working Memory.
47 Protto S et al. TREVO and Capture LP have equal technical success rates in mechanical thrombectomy of proximal and distal anterior circulation occlusions.
48 Protto S et al. Low Cerebral Blood Volume Identifies Poor Outcome in Stent Retriever Thrombectomy.
49 Rainesalo S et al. Clinical management of elderly patients with epilepsy; the use of lacosamide in a single center setting.
50 Rossi D et al. A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy.
51 Rosti-Otajärvi E, Hämäläinen P. Uupumus MS-taudissa.
52 Rosti-Otajärvi E et al. Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients.
53 Rosti-Otajärvi E et al. Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale-29.
54 Saunamäki T et al. CPAP Treatment Partly Normalizes Sleep Spindle Features in Obstructive Sleep Apnea.
55 Saunamäki T et al. Uniapnean kognitiiviset vaikutukset ja työkyky.
56 Shorvon S et al. Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
57 Sillanpää N et al. Internal Carotid Artery and the Proximal M1 Segment Are Optimal Targets for Mechanical Thrombectomy.
58 Sivula A et al. FOUR-pisteytys tehohoitopotilaan tajunnantilan seurannassa: ensimmäiset kokemukset suomennetun version käytöstä.
59 Sun L et al. Vagus nerve stimulation improves working memory performance.
60 Thesleff T. Cervical Spine Injuries : Epidemiology and diagnostic challenges.
61 Thesleff T et al. Head injuries and the risk of concurrent cervical spine fractures.
62 Thesleff T et al. Erratum to: Head injuries and the risk of concurrent cervical spine fractures.
63 Thesleff T et al. Head injuries and the risk of concurrent cervical spine fractures (vol 159, pg 907, 2017) .
64 Thesleff T et al. Cranioplasty with Adipose-Derived Stem Cells, Beta-Tricalcium Phosphate Granules and Supporting Mesh: Six-Year Clinical Follow-Up Results.
65 Thorén M et al. Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis.
66 Tienari P, Hietaharju A. Neurologiset autoimmuunitaudit - multippeliskleroosi ja Guillain-Barrén oireyhtymä.
67 Tuominen M et al. Concussion in the international ice hockey World Championships and Olympic Winter Games between 2006 and 2015.
68 Udd B. Perinnölliset lihassairaudet.
69 Vainionpää A et al. Selkäydinvammaisen hyvä kuntoutuskäytäntö.
70 Vistbakka J et al. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
71 Väärälä E et al. Hoidon keskittäminen nopeuttaa selkäydinvammapotilaan kotiutumista.
72 Walker L et al. Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy.

Julkaisutietokanta 20.6.2018 Publications Data Base 20.6.2018